Table 1.
Baseline characteristics of participants.
| SCTV01C |
||||||
|---|---|---|---|---|---|---|
| Saline (N = 75) | 20 μg (N = 79) | 40 μg (N = 80) | Total (N = 159) | Overall (N = 234) | p valuea | |
| Age (years) | 0.58 | |||||
| N (missing) | 75 (0) | 79 (0) | 80 (0) | 159 (0) | 234 (0) | |
| Mean (SD) | 29.1 (7.73) | 28.8 (6.97) | 29.4 (7.88) | 29.1 (7.43) | 29.1 (7.51) | |
| Median | 28.0 | 28.0 | 28.0 | 28.0 | 28.0 | |
| Range | (19, 58) | (19, 51) | (19, 53) | (19, 53) | (19, 58) | |
| Sex | 0.77 | |||||
| Female n (%) | 0 | 0 | 2 (2.5) | 2 (1.3) | 2 (0.9) | |
| Male n (%) | 75 (100) | 79 (100) | 78 (97.5) | 157 (98.7) | 232 (99.1) | |
| Race | 0.32 | |||||
| Asian n (%) | 75 (100) | 78 (98.7) | 79 (98.8) | 157 (98.7) | 232 (99.1) | |
| Black n (%) | 0 | 1 (1.3) | 0 | 1 (0.6) | 1 (0.4) | |
| Other n (%) | 0 | 0 | 1 (1.3) | 1 (0.6) | 1 (0.4) | |
| BMI (kg/m2) | 0.17 | |||||
| N (missing) | 75 (0) | 78 (1) | 79 (1) | 157 (2) | 232 (2) | |
| Mean (SD) | 24.3 (4.16) | 24.2 (4.31) | 22.8 (3.59) | 23.5 (4.01) | 23.8 (4.07) | |
| Median | 23.7 | 23.65 | 22.2 | 23.2 | 23.4 | |
| Range | (17.0, 36.1) | (15.8, 40.4) | (16.2, 34.7) | (15.8, 40.4) | (15.8, 40.4) | |
| Allergic history | 0.54 | |||||
| Yes n (%) | 1 (1.3) | 0 | 2 (2.5) | 2 (1.3) | 3 (1.3) | |
| No n (%) | 74 (98.7) | 79 (100.0) | 78 (97.5) | 157 (98.7) | 231 (98.7) | |
| History of SARS-COV-2 vaccination | – | |||||
| Yes n (%) | 75 (100) | 79 (100) | 80 (100) | 159 (100) | 234 (100) | |
| No n (%) | 0 | 0 | 0 | 0 | 0 | |
| Interval from last vaccine (months) | 0.12 | |||||
| N (missing) | 74 (1) | 79 (0) | 76 (4) | 155 (4) | 229 (5) | |
| Mean (SD) | 6.9 (2.0) | 6.2 (2.0) | 6.9 (2.3) | 6.6 (2.2) | 6.7 (2.1) | |
| Median | 7.0 | 5.8 | 6.9 | 6.5 | 6.7 | |
| Min, Max | 3.2, 10.9 | 3.3, 12.0 | 2.2, 10.9 | 2.2, 12 | 2.2, 12 | |
| Comorbidities n (%) | – | |||||
| Hypertension | 0 | 1 (1.3) | 0 | 1 (0.6) | 1 (0.4) | |
| Diabetes mellitus | 0 | 2 (2.5) | 0 | 2 (1.3) | 2 (0.9) | |
| Glucose tolerance impaired | 0 | 1 (1.3) | 0 | 1 (0.6) | 1 (0.4) | |
| Gastrointestinal disorders | 0 | 0 | 1 (1.3) | 1 (0.6) | 1 (0.4) | |
| Malignancy | 0 | 0 | 0 | 0 | 0 | |
| Hepatitis E | 0 | 1 (1.3) | 0 | 1 (0.6) | 1 (0.4) | |
BMI = Body Mass Index; SD = Standard Deviation.
a
Statistical analysis between saline group and total (SCTV01C 20 μg group + SCTV01C 40 μg group) group.